Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy in the elderly.

R E Ramsay1, F Pryor

  • 1Department of Neurology, University of Miami School of Medicine, Miami Veterans Affairs Medical Center, FL 33136, USA.

Neurology
|September 23, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Buna Joe "BJ" Wilder, MD (1929-2023).

Neurology·2024
Same author

Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures.

Acta neurologica Scandinavica. Supplementum·2013
Same author

Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.

Clinical pharmacology and therapeutics·2012
Same author

Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.

Neurology·2008
Same author

Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004.

Neurology·2008
Same author

New developments in the treatment of epilepsy.

CNS spectrums·2008
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Epilepsy treatment in older adults requires careful drug selection. Newer antiepileptic drugs (AEDs) offer benefits, but age-related changes necessitate personalized dosing strategies.

Area of Science:

  • Geriatric Medicine
  • Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy incidence is notably high in the elderly population.
  • Understanding seizure types, clinical presentations, and treatment is crucial for this demographic.

Purpose of the Study:

  • To review first-line antiepileptic drugs (AEDs) for elderly patients.
  • To discuss the role of newer AEDs considering efficacy and side-effect profiles.
  • To highlight factors influencing drug and dosage selection in geriatric epilepsy management.

Main Methods:

  • Literature review of established and newer antiepileptic drugs.
  • Analysis of age-related physiological and pharmacokinetic changes.
  • Consideration of drug interactions, administration routes, and cost-effectiveness.

Related Experiment Videos

Main Results:

  • Traditional first-line AEDs include carbamazepine, phenytoin, and valproic acid.
  • Newer AEDs like gabapentin, lamotrigine, and tiagabine show promise due to efficacy and better tolerability.
  • Aging impacts drug pharmacokinetics and increases susceptibility to adverse effects.

Conclusions:

  • Individualized treatment selection is paramount for elderly epilepsy patients.
  • Factors such as age-related changes, drug interactions, and side-effect profiles must guide therapy.
  • Balancing efficacy, safety, and cost is essential for optimal geriatric epilepsy management.